Global Oncolytic Virus Immunotherapy Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Oncolytic Virus Immunotherapy market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Oncolytic Virus Immunotherapy market are covered in Chapter 9:
Sorrento Therapeutics Inc.
Merck & Co., Inc.
Shanghai Sunway Biotech Co., Ltd.
Oncolytics Biotech, Inc.
ORYX GmbH & Co. KG
Transgene Biotek Ltd.
Viralytics Ltd.
SillaJen, Inc.
Cold Genesys, Inc.
Amgen, Inc.
RIGVIR Ltd.
In Chapter 5 and Chapter 7.3, based on types, the Oncolytic Virus Immunotherapy market from 2017 to 2027 is primarily split into:
HSV-based Oncolytic Viruses
Adenovirus-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
In Chapter 6 and Chapter 7.4, based on applications, the Oncolytic Virus Immunotherapy market from 2017 to 2027 covers:
Hospitals
Specialty Clinics
Cancer Research Institutes
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Oncolytic Virus Immunotherapy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Oncolytic Virus Immunotherapy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Oncolytic Virus Immunotherapy market are covered in Chapter 9:
Sorrento Therapeutics Inc.
Merck & Co., Inc.
Shanghai Sunway Biotech Co., Ltd.
Oncolytics Biotech, Inc.
ORYX GmbH & Co. KG
Transgene Biotek Ltd.
Viralytics Ltd.
SillaJen, Inc.
Cold Genesys, Inc.
Amgen, Inc.
RIGVIR Ltd.
In Chapter 5 and Chapter 7.3, based on types, the Oncolytic Virus Immunotherapy market from 2017 to 2027 is primarily split into:
HSV-based Oncolytic Viruses
Adenovirus-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
In Chapter 6 and Chapter 7.4, based on applications, the Oncolytic Virus Immunotherapy market from 2017 to 2027 covers:
Hospitals
Specialty Clinics
Cancer Research Institutes
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Oncolytic Virus Immunotherapy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Oncolytic Virus Immunotherapy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET OVERVIEW
1.1 Product Overview and Scope of Oncolytic Virus Immunotherapy Market
1.2 Oncolytic Virus Immunotherapy Market Segment by Type
1.2.1 Global Oncolytic Virus Immunotherapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Oncolytic Virus Immunotherapy Market Segment by Application
1.3.1 Oncolytic Virus Immunotherapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Oncolytic Virus Immunotherapy Market, Region Wise (2017-2027)
1.4.1 Global Oncolytic Virus Immunotherapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.3 Europe Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.4 China Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.5 Japan Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.6 India Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.8 Latin America Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Oncolytic Virus Immunotherapy (2017-2027)
1.5.1 Global Oncolytic Virus Immunotherapy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Oncolytic Virus Immunotherapy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Oncolytic Virus Immunotherapy Market
2 INDUSTRY OUTLOOK
2.1 Oncolytic Virus Immunotherapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Oncolytic Virus Immunotherapy Market Drivers Analysis
2.4 Oncolytic Virus Immunotherapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Oncolytic Virus Immunotherapy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Oncolytic Virus Immunotherapy Industry Development
3 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET LANDSCAPE BY PLAYER
3.1 Global Oncolytic Virus Immunotherapy Sales Volume and Share by Player (2017-2022)
3.2 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Player (2017-2022)
3.3 Global Oncolytic Virus Immunotherapy Average Price by Player (2017-2022)
3.4 Global Oncolytic Virus Immunotherapy Gross Margin by Player (2017-2022)
3.5 Oncolytic Virus Immunotherapy Market Competitive Situation and Trends
3.5.1 Oncolytic Virus Immunotherapy Market Concentration Rate
3.5.2 Oncolytic Virus Immunotherapy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Oncolytic Virus Immunotherapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Oncolytic Virus Immunotherapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Oncolytic Virus Immunotherapy Market Under COVID-19
4.5 Europe Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Oncolytic Virus Immunotherapy Market Under COVID-19
4.6 China Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Oncolytic Virus Immunotherapy Market Under COVID-19
4.7 Japan Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Oncolytic Virus Immunotherapy Market Under COVID-19
4.8 India Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Oncolytic Virus Immunotherapy Market Under COVID-19
4.9 Southeast Asia Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Oncolytic Virus Immunotherapy Market Under COVID-19
4.10 Latin America Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Oncolytic Virus Immunotherapy Market Under COVID-19
4.11 Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Oncolytic Virus Immunotherapy Market Under COVID-19
5 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Oncolytic Virus Immunotherapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2017-2022)
5.3 Global Oncolytic Virus Immunotherapy Price by Type (2017-2022)
5.4 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of HSV-based Oncolytic Viruses (2017-2022)
5.4.2 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of Adenovirus-based Oncolytic Viruses (2017-2022)
5.4.3 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2017-2022)
5.4.4 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2017-2022)
5.4.5 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2017-2022)
6 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET ANALYSIS BY APPLICATION
6.1 Global Oncolytic Virus Immunotherapy Consumption and Market Share by Application (2017-2022)
6.2 Global Oncolytic Virus Immunotherapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Specialty Clinics (2017-2022)
6.3.3 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Cancer Research Institutes (2017-2022)
7 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET FORECAST (2022-2027)
7.1 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Oncolytic Virus Immunotherapy Price and Trend Forecast (2022-2027)
7.2 Global Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of HSV-based Oncolytic Viruses (2022-2027)
7.3.2 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of Adenovirus-based Oncolytic Viruses (2022-2027)
7.3.3 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2022-2027)
7.3.4 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2022-2027)
7.3.5 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2022-2027)
7.4 Global Oncolytic Virus Immunotherapy Consumption Forecast by Application (2022-2027)
7.4.1 Global Oncolytic Virus Immunotherapy Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Oncolytic Virus Immunotherapy Consumption Value and Growth Rate of Specialty Clinics(2022-2027)
7.4.3 Global Oncolytic Virus Immunotherapy Consumption Value and Growth Rate of Cancer Research Institutes(2022-2027)
7.5 Oncolytic Virus Immunotherapy Market Forecast Under COVID-19
8 ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Oncolytic Virus Immunotherapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Oncolytic Virus Immunotherapy Analysis
8.6 Major Downstream Buyers of Oncolytic Virus Immunotherapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Oncolytic Virus Immunotherapy Industry
9 PLAYERS PROFILES
9.1 Sorrento Therapeutics Inc.
9.1.1 Sorrento Therapeutics Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.1.3 Sorrento Therapeutics Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Merck & Co., Inc.
9.2.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.2.3 Merck & Co., Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Shanghai Sunway Biotech Co., Ltd.
9.3.1 Shanghai Sunway Biotech Co., Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.3.3 Shanghai Sunway Biotech Co., Ltd. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Oncolytics Biotech, Inc.
9.4.1 Oncolytics Biotech, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.4.3 Oncolytics Biotech, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 ORYX GmbH & Co. KG
9.5.1 ORYX GmbH & Co. KG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.5.3 ORYX GmbH & Co. KG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Transgene Biotek Ltd.
9.6.1 Transgene Biotek Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.6.3 Transgene Biotek Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Viralytics Ltd.
9.7.1 Viralytics Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.7.3 Viralytics Ltd. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 SillaJen, Inc.
9.8.1 SillaJen, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.8.3 SillaJen, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Cold Genesys, Inc.
9.9.1 Cold Genesys, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.9.3 Cold Genesys, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Amgen, Inc.
9.10.1 Amgen, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.10.3 Amgen, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 RIGVIR Ltd.
9.11.1 RIGVIR Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.11.3 RIGVIR Ltd. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Oncolytic Virus Immunotherapy Market
1.2 Oncolytic Virus Immunotherapy Market Segment by Type
1.2.1 Global Oncolytic Virus Immunotherapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Oncolytic Virus Immunotherapy Market Segment by Application
1.3.1 Oncolytic Virus Immunotherapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Oncolytic Virus Immunotherapy Market, Region Wise (2017-2027)
1.4.1 Global Oncolytic Virus Immunotherapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.3 Europe Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.4 China Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.5 Japan Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.6 India Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.8 Latin America Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Oncolytic Virus Immunotherapy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Oncolytic Virus Immunotherapy (2017-2027)
1.5.1 Global Oncolytic Virus Immunotherapy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Oncolytic Virus Immunotherapy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Oncolytic Virus Immunotherapy Market
2 INDUSTRY OUTLOOK
2.1 Oncolytic Virus Immunotherapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Oncolytic Virus Immunotherapy Market Drivers Analysis
2.4 Oncolytic Virus Immunotherapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Oncolytic Virus Immunotherapy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Oncolytic Virus Immunotherapy Industry Development
3 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET LANDSCAPE BY PLAYER
3.1 Global Oncolytic Virus Immunotherapy Sales Volume and Share by Player (2017-2022)
3.2 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Player (2017-2022)
3.3 Global Oncolytic Virus Immunotherapy Average Price by Player (2017-2022)
3.4 Global Oncolytic Virus Immunotherapy Gross Margin by Player (2017-2022)
3.5 Oncolytic Virus Immunotherapy Market Competitive Situation and Trends
3.5.1 Oncolytic Virus Immunotherapy Market Concentration Rate
3.5.2 Oncolytic Virus Immunotherapy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Oncolytic Virus Immunotherapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Oncolytic Virus Immunotherapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Oncolytic Virus Immunotherapy Market Under COVID-19
4.5 Europe Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Oncolytic Virus Immunotherapy Market Under COVID-19
4.6 China Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Oncolytic Virus Immunotherapy Market Under COVID-19
4.7 Japan Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Oncolytic Virus Immunotherapy Market Under COVID-19
4.8 India Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Oncolytic Virus Immunotherapy Market Under COVID-19
4.9 Southeast Asia Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Oncolytic Virus Immunotherapy Market Under COVID-19
4.10 Latin America Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Oncolytic Virus Immunotherapy Market Under COVID-19
4.11 Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Oncolytic Virus Immunotherapy Market Under COVID-19
5 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Oncolytic Virus Immunotherapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Oncolytic Virus Immunotherapy Revenue and Market Share by Type (2017-2022)
5.3 Global Oncolytic Virus Immunotherapy Price by Type (2017-2022)
5.4 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of HSV-based Oncolytic Viruses (2017-2022)
5.4.2 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of Adenovirus-based Oncolytic Viruses (2017-2022)
5.4.3 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2017-2022)
5.4.4 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2017-2022)
5.4.5 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2017-2022)
6 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET ANALYSIS BY APPLICATION
6.1 Global Oncolytic Virus Immunotherapy Consumption and Market Share by Application (2017-2022)
6.2 Global Oncolytic Virus Immunotherapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Specialty Clinics (2017-2022)
6.3.3 Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Cancer Research Institutes (2017-2022)
7 GLOBAL ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET FORECAST (2022-2027)
7.1 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Oncolytic Virus Immunotherapy Price and Trend Forecast (2022-2027)
7.2 Global Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Oncolytic Virus Immunotherapy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of HSV-based Oncolytic Viruses (2022-2027)
7.3.2 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of Adenovirus-based Oncolytic Viruses (2022-2027)
7.3.3 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2022-2027)
7.3.4 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2022-2027)
7.3.5 Global Oncolytic Virus Immunotherapy Revenue and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2022-2027)
7.4 Global Oncolytic Virus Immunotherapy Consumption Forecast by Application (2022-2027)
7.4.1 Global Oncolytic Virus Immunotherapy Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Oncolytic Virus Immunotherapy Consumption Value and Growth Rate of Specialty Clinics(2022-2027)
7.4.3 Global Oncolytic Virus Immunotherapy Consumption Value and Growth Rate of Cancer Research Institutes(2022-2027)
7.5 Oncolytic Virus Immunotherapy Market Forecast Under COVID-19
8 ONCOLYTIC VIRUS IMMUNOTHERAPY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Oncolytic Virus Immunotherapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Oncolytic Virus Immunotherapy Analysis
8.6 Major Downstream Buyers of Oncolytic Virus Immunotherapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Oncolytic Virus Immunotherapy Industry
9 PLAYERS PROFILES
9.1 Sorrento Therapeutics Inc.
9.1.1 Sorrento Therapeutics Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.1.3 Sorrento Therapeutics Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Merck & Co., Inc.
9.2.1 Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.2.3 Merck & Co., Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Shanghai Sunway Biotech Co., Ltd.
9.3.1 Shanghai Sunway Biotech Co., Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.3.3 Shanghai Sunway Biotech Co., Ltd. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Oncolytics Biotech, Inc.
9.4.1 Oncolytics Biotech, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.4.3 Oncolytics Biotech, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 ORYX GmbH & Co. KG
9.5.1 ORYX GmbH & Co. KG Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.5.3 ORYX GmbH & Co. KG Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Transgene Biotek Ltd.
9.6.1 Transgene Biotek Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.6.3 Transgene Biotek Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Viralytics Ltd.
9.7.1 Viralytics Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.7.3 Viralytics Ltd. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 SillaJen, Inc.
9.8.1 SillaJen, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.8.3 SillaJen, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Cold Genesys, Inc.
9.9.1 Cold Genesys, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.9.3 Cold Genesys, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Amgen, Inc.
9.10.1 Amgen, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.10.3 Amgen, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 RIGVIR Ltd.
9.11.1 RIGVIR Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Oncolytic Virus Immunotherapy Product Profiles, Application and Specification
9.11.3 RIGVIR Ltd. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Oncolytic Virus Immunotherapy Product Picture
Table Global Oncolytic Virus Immunotherapy Market Sales Volume and CAGR (%) Comparison by Type
Table Oncolytic Virus Immunotherapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Oncolytic Virus Immunotherapy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Oncolytic Virus Immunotherapy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Oncolytic Virus Immunotherapy Industry Development
Table Global Oncolytic Virus Immunotherapy Sales Volume by Player (2017-2022)
Table Global Oncolytic Virus Immunotherapy Sales Volume Share by Player (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume Share by Player in 2021
Table Oncolytic Virus Immunotherapy Revenue (Million USD) by Player (2017-2022)
Table Oncolytic Virus Immunotherapy Revenue Market Share by Player (2017-2022)
Table Oncolytic Virus Immunotherapy Price by Player (2017-2022)
Table Oncolytic Virus Immunotherapy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncolytic Virus Immunotherapy Sales Volume, Region Wise (2017-2022)
Table Global Oncolytic Virus Immunotherapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume Market Share, Region Wise in 2021
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD), Region Wise (2017-2022)
Table Global Oncolytic Virus Immunotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share, Region Wise in 2021
Table Global Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Oncolytic Virus Immunotherapy Sales Volume by Type (2017-2022)
Table Global Oncolytic Virus Immunotherapy Sales Volume Market Share by Type (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume Market Share by Type in 2021
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Type (2017-2022)
Table Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Type in 2021
Table Oncolytic Virus Immunotherapy Price by Type (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of HSV-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of HSV-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of Adenovirus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Adenovirus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption by Application (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption Market Share by Application (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption Revenue Market Share by Application (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Specialty Clinics (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Cancer Research Institutes (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Price and Trend Forecast (2022-2027)
Figure USA Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Oncolytic Virus Immunotherapy Market Sales Volume Forecast, by Type
Table Global Oncolytic Virus Immunotherapy Sales Volume Market Share Forecast, by Type
Table Global Oncolytic Virus Immunotherapy Market Revenue (Million USD) Forecast, by Type
Table Global Oncolytic Virus Immunotherapy Revenue Market Share Forecast, by Type
Table Global Oncolytic Virus Immunotherapy Price Forecast, by Type
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of HSV-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of HSV-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Adenovirus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Adenovirus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2022-2027)
Table Global Oncolytic Virus Immunotherapy Market Consumption Forecast, by Application
Table Global Oncolytic Virus Immunotherapy Consumption Market Share Forecast, by Application
Table Global Oncolytic Virus Immunotherapy Market Revenue (Million USD) Forecast, by Application
Table Global Oncolytic Virus Immunotherapy Revenue Market Share Forecast, by Application
Figure Global Oncolytic Virus Immunotherapy Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Consumption Value (Million USD) and Growth Rate of Specialty Clinics (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Consumption Value (Million USD) and Growth Rate of Cancer Research Institutes (2022-2027)
Figure Oncolytic Virus Immunotherapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Sorrento Therapeutics Inc. Profile
Table Sorrento Therapeutics Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sorrento Therapeutics Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Sorrento Therapeutics Inc. Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Merck & Co., Inc. Revenue (Million USD) Market Share 2017-2022
Table Shanghai Sunway Biotech Co., Ltd. Profile
Table Shanghai Sunway Biotech Co., Ltd. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shanghai Sunway Biotech Co., Ltd. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Shanghai Sunway Biotech Co., Ltd. Revenue (Million USD) Market Share 2017-2022
Table Oncolytics Biotech, Inc. Profile
Table Oncolytics Biotech, Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Oncolytics Biotech, Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Oncolytics Biotech, Inc. Revenue (Million USD) Market Share 2017-2022
Table ORYX GmbH & Co. KG Profile
Table ORYX GmbH & Co. KG Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ORYX GmbH & Co. KG Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure ORYX GmbH & Co. KG Revenue (Million USD) Market Share 2017-2022
Table Transgene Biotek Ltd. Profile
Table Transgene Biotek Ltd. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Transgene Biotek Ltd. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Transgene Biotek Ltd. Revenue (Million USD) Market Share 2017-2022
Table Viralytics Ltd. Profile
Table Viralytics Ltd. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Viralytics Ltd. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Viralytics Ltd. Revenue (Million USD) Market Share 2017-2022
Table SillaJen, Inc. Profile
Table SillaJen, Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure SillaJen, Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure SillaJen, Inc. Revenue (Million USD) Market Share 2017-2022
Table Cold Genesys, Inc. Profile
Table Cold Genesys, Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cold Genesys, Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Cold Genesys, Inc. Revenue (Million USD) Market Share 2017-2022
Table Amgen, Inc. Profile
Table Amgen, Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen, Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Amgen, Inc. Revenue (Million USD) Market Share 2017-2022
Table RIGVIR Ltd. Profile
Table RIGVIR Ltd. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure RIGVIR Ltd. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure RIGVIR Ltd. Revenue (Million USD) Market Share 2017-2022
Figure Oncolytic Virus Immunotherapy Product Picture
Table Global Oncolytic Virus Immunotherapy Market Sales Volume and CAGR (%) Comparison by Type
Table Oncolytic Virus Immunotherapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Oncolytic Virus Immunotherapy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Oncolytic Virus Immunotherapy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Oncolytic Virus Immunotherapy Industry Development
Table Global Oncolytic Virus Immunotherapy Sales Volume by Player (2017-2022)
Table Global Oncolytic Virus Immunotherapy Sales Volume Share by Player (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume Share by Player in 2021
Table Oncolytic Virus Immunotherapy Revenue (Million USD) by Player (2017-2022)
Table Oncolytic Virus Immunotherapy Revenue Market Share by Player (2017-2022)
Table Oncolytic Virus Immunotherapy Price by Player (2017-2022)
Table Oncolytic Virus Immunotherapy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Oncolytic Virus Immunotherapy Sales Volume, Region Wise (2017-2022)
Table Global Oncolytic Virus Immunotherapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume Market Share, Region Wise in 2021
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD), Region Wise (2017-2022)
Table Global Oncolytic Virus Immunotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share, Region Wise in 2021
Table Global Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Oncolytic Virus Immunotherapy Sales Volume by Type (2017-2022)
Table Global Oncolytic Virus Immunotherapy Sales Volume Market Share by Type (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume Market Share by Type in 2021
Table Global Oncolytic Virus Immunotherapy Revenue (Million USD) by Type (2017-2022)
Table Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue Market Share by Type in 2021
Table Oncolytic Virus Immunotherapy Price by Type (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of HSV-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of HSV-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of Adenovirus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Adenovirus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption by Application (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption Market Share by Application (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption Revenue Market Share by Application (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Specialty Clinics (2017-2022)
Table Global Oncolytic Virus Immunotherapy Consumption and Growth Rate of Cancer Research Institutes (2017-2022)
Figure Global Oncolytic Virus Immunotherapy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Price and Trend Forecast (2022-2027)
Figure USA Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Oncolytic Virus Immunotherapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Oncolytic Virus Immunotherapy Market Sales Volume Forecast, by Type
Table Global Oncolytic Virus Immunotherapy Sales Volume Market Share Forecast, by Type
Table Global Oncolytic Virus Immunotherapy Market Revenue (Million USD) Forecast, by Type
Table Global Oncolytic Virus Immunotherapy Revenue Market Share Forecast, by Type
Table Global Oncolytic Virus Immunotherapy Price Forecast, by Type
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of HSV-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of HSV-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Adenovirus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Adenovirus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vaccinia Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Vesicular Stomatitis Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Revenue (Million USD) and Growth Rate of Newcastle Disease Virus-based Oncolytic Viruses (2022-2027)
Table Global Oncolytic Virus Immunotherapy Market Consumption Forecast, by Application
Table Global Oncolytic Virus Immunotherapy Consumption Market Share Forecast, by Application
Table Global Oncolytic Virus Immunotherapy Market Revenue (Million USD) Forecast, by Application
Table Global Oncolytic Virus Immunotherapy Revenue Market Share Forecast, by Application
Figure Global Oncolytic Virus Immunotherapy Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Consumption Value (Million USD) and Growth Rate of Specialty Clinics (2022-2027)
Figure Global Oncolytic Virus Immunotherapy Consumption Value (Million USD) and Growth Rate of Cancer Research Institutes (2022-2027)
Figure Oncolytic Virus Immunotherapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Sorrento Therapeutics Inc. Profile
Table Sorrento Therapeutics Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sorrento Therapeutics Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Sorrento Therapeutics Inc. Revenue (Million USD) Market Share 2017-2022
Table Merck & Co., Inc. Profile
Table Merck & Co., Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Merck & Co., Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Merck & Co., Inc. Revenue (Million USD) Market Share 2017-2022
Table Shanghai Sunway Biotech Co., Ltd. Profile
Table Shanghai Sunway Biotech Co., Ltd. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shanghai Sunway Biotech Co., Ltd. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Shanghai Sunway Biotech Co., Ltd. Revenue (Million USD) Market Share 2017-2022
Table Oncolytics Biotech, Inc. Profile
Table Oncolytics Biotech, Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Oncolytics Biotech, Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Oncolytics Biotech, Inc. Revenue (Million USD) Market Share 2017-2022
Table ORYX GmbH & Co. KG Profile
Table ORYX GmbH & Co. KG Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ORYX GmbH & Co. KG Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure ORYX GmbH & Co. KG Revenue (Million USD) Market Share 2017-2022
Table Transgene Biotek Ltd. Profile
Table Transgene Biotek Ltd. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Transgene Biotek Ltd. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Transgene Biotek Ltd. Revenue (Million USD) Market Share 2017-2022
Table Viralytics Ltd. Profile
Table Viralytics Ltd. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Viralytics Ltd. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Viralytics Ltd. Revenue (Million USD) Market Share 2017-2022
Table SillaJen, Inc. Profile
Table SillaJen, Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure SillaJen, Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure SillaJen, Inc. Revenue (Million USD) Market Share 2017-2022
Table Cold Genesys, Inc. Profile
Table Cold Genesys, Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cold Genesys, Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Cold Genesys, Inc. Revenue (Million USD) Market Share 2017-2022
Table Amgen, Inc. Profile
Table Amgen, Inc. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen, Inc. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure Amgen, Inc. Revenue (Million USD) Market Share 2017-2022
Table RIGVIR Ltd. Profile
Table RIGVIR Ltd. Oncolytic Virus Immunotherapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure RIGVIR Ltd. Oncolytic Virus Immunotherapy Sales Volume and Growth Rate
Figure RIGVIR Ltd. Revenue (Million USD) Market Share 2017-2022
